Maternal Immune Cell and Cytokine Profiles to Predict Cardiovascular Risk Six Months after Preeclampsia
Authors:
- Malia S. Q. MurphyMMMalia S. Q. Murphy
- Samantha J. BentonSBSamantha J. Benton
- Brian CoxBCBrian Cox
- Kara NerenbergKNKara Nerenberg
- Scott McCombScott McComb
- Lakshmi KrishnanLKLakshmi Krishnan
- Risini D. WeeratnaRisini D. Weeratna
- Jean-François ParéJPJean-François Paré
- Alysha L. J. Dingwall-HarveyADAlysha L. J. Dingwall-Harvey
- Shannon A. BainbridgeShannon A. Bainbridge
- Andrée GruslinAGAndrée Gruslin
- Laura M. GaudetLGLaura M. Gaudet
Open Access
- 19 July 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (14) , 4185
Abstract
Women who develop preeclampsia (PE) are at high risk for cardiovascular disease (CVD). Early identification of women with PE who may benefit the most from early cardiovascular risk screening and interventions remains challenging. Our objective was to assess whether cytokine and immune cell profiles after PE are helpful in distinguishing women at low and high CVD risk at 6-months postpartum. Individuals who developed PE were followed for immune cell phenotyping and plasma cytokine quantification at delivery, at 3-months, and at 6-months postpartum. Lifetime CVD risk was assessed at 6-months postpartum, and the immune cell and cytokine profiles were compared between risk groups at each time point. Among 31 participants, 18 (58.1%) exhibited high CVD-risk profiles at 6-months postpartum. The proportion of circulating NK-cells was significantly lower in high-risk participants at delivery (p = 0.04). At 3-months postpartum, high-risk participants exhibited a lower proportion of FoxP3+ regulatory T-cells (p = 0.01), a greater proportion of CD8+ T cells (p = 0.02) and a lower CD4+:CD8+ ratio (p = 0.02). There were no differences in immune cell populations at 6-months postpartum. There were no differences in plasma cytokines levels between risk groups at any time point. Subtle differences in immune cell profiles may help distinguish individuals at low and high CVD risk in the early postpartum period and warrants further investigation.Keywords
Funding Information
- Ottawa Hospital Academic Medical Organization (TOHAMO)
This publication has 42 references indexed in Scilit:
- Cardiovascular risk estimation in women with a history of hypertensive pregnancy disorders at term: a longitudinal follow-up studyBMC Pregnancy and Childbirth, 2013
- Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosisJournal of Clinical Investigation, 2013
- Circulating biomarkers with preventive, diagnostic and prognostic implications in cardiovascular diseasesInternational Journal of Cardiology, 2012
- Maternal Serum Levels of TNF-Alpha and IL-6 Long after Delivery in Preeclamptic and Normotensive Pregnant WomenMediators of Inflammation, 2010
- Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension arrayBMC Immunology, 2010
- Pregnancy: a “teachable moment” for weight control and obesity preventionAmerican Journal of Obstetrics and Gynecology, 2010
- Multimarker Approach Predicts Adverse Cardiovascular Events in Women Evaluated for Suspected Ischemia: Results from the National Heart, Lung, and Blood Institute–Sponsored Women's Ischemia Syndrome EvaluationClinical Cardiology, 2009
- Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysisBMJ, 2007
- Abnormal Endothelium-Dependent Microvascular Reactivity in Recently Preeclamptic WomenObstetrics & Gynecology, 2005
- Inflammatory Markers and Onset of Cardiovascular EventsCirculation, 2003